Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
LeMaitre Vascular, Inc. +1.52%
LeMaitre Vascular, Inc. LMAT | 94.04 | +1.52% |
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:
LMAT) with a Outperform and raises the price target from $92 to $93.
